AIM
PCRX icon

AIA Investment Management’s Pacira BioSciences PCRX Stock Holding History

AIA Investment Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$1.95M Buy
32,452
+13,513
+71% +$785K 0.45% 52
2020
Q2 		$994K Buy
18,939
+814
+4% +$34K 0.23% 60
2020
Q1 		$608K Buy
+18,125
New +$753K 0.13% 59

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AIA Investment Management's PCRX Position: Q3 2020 in Review

AIA Investment Management increased its Pacira BioSciences (PCRX) stake by 71% in Q3 2020, buying an estimated $785K and bringing the position to 32,452 shares worth $1.95M. The position accounts for 0.45% of the portfolio, ranked #52.

AIA Investment Management first reported a position in PCRX in Q1 2020 and has held it in 3 quarters since. 257 funds tracked by Wall St. Rank hold PCRX as of Q3 2020.

  • AIA Investment Management held 32,452 shares of Pacira BioSciences worth $1.95M as of Q3 2020.
  • AIA Investment Management bought 13,513 Pacira BioSciences shares in Q3 2020, an estimated $785K.
  • Pacira BioSciences made up 0.45% of AIA Investment Management's portfolio in Q3 2020, its #52 holding.
  • AIA Investment Management first reported a position in Pacira BioSciences in Q1 2020 and has held it in 3 quarters since.
  • 257 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2020.

Based on AIA Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.